ArticleClinical & developmental immunology2013

Potential survival benefit of anti-apoptosis protein: survivin-derived peptide vaccine with and without interferon alpha therapy for patients with advanced or recurrent urothelial cancer--results from phase I clinical trials.

Toshiaki Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.